Osaic Holdings
ATNM icon

Osaic Holdings’s Actinium Pharmaceuticals ATNM Stock Holding History

Osaic Holdings’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5K Sell
18,865
-1,000
-5% -$1.16K ﹤0.01% 6230
2026
Q1 		$19.9K Sell
19,865
-400
-2% -$476 ﹤0.01% 5866
2025
Q4 		$27.6K Buy
20,265
+13,115
+183% +$19.1K ﹤0.01% 5642
2025
Q3 		$12.2K Hold
7,150
– – ﹤0.01% 6238
2025
Q2 		$10K Sell
7,150
-775
-10% -$1.16K ﹤0.01% 6142
2025
Q1 		$12.8K Buy
7,925
+1,500
+23% +$1.9K ﹤0.01% 5648
2024
Q4 		$8.1K Sell
6,425
-3,864
-38% -$6K ﹤0.01% 5916
2024
Q3 		$19.3K Sell
10,289
-216
-2% -$853 ﹤0.01% 5408
2024
Q2 		$77.4K Buy
10,505
+355
+3% +$2.92K ﹤0.01% 4346
2024
Q1 		$80.9K Buy
10,150
+3,500
+53% +$22.5K ﹤0.01% 4391
2023
Q4 		$33.8K Sell
6,650
-666
-9% -$3.43K ﹤0.01% 5154
2023
Q3 		$43.3K Buy
7,316
+4,500
+160% +$29.9K ﹤0.01% 5083
2023
Q2 		$20.8K Hold
2,816
– – ﹤0.01% 5535
2023
Q1 		$26.4K Sell
2,816
-200
-7% -$2.11K ﹤0.01% 5399
2022
Q4 		$33K Buy
3,016
+200
+7% +$2.03K ﹤0.01% 5220
2022
Q3 		$21K Hold
2,816
– – ﹤0.01% 5538
2022
Q2 		$14K Hold
2,816
– – ﹤0.01% 5841
2022
Q1 		$13K Buy
2,816
+1,000
+55% +$5.27K ﹤0.01% 5967
2021
Q4 		$12K Sell
1,816
-1,396
-43% -$10.5K ﹤0.01% 6125
2021
Q3 		$28K Buy
3,212
+614
+24% +$4.27K ﹤0.01% 5528
2021
Q2 		$20K Buy
2,598
+375
+17% +$2.94K ﹤0.01% 5649
2021
Q1 		$17K Buy
2,223
+977
+78% +$8.3K ﹤0.01% 5579
2020
Q4 		$9K Buy
1,246
+365
+41% +$3.96K ﹤0.01% 5546
2020
Q3 		$9K Sell
881
-1,453
-62% -$16K ﹤0.01% 5308
2020
Q2 		$25K Buy
2,334
+166
+8% +$1.26K ﹤0.01% 4655
2020
Q1 		$13K Buy
+2,168
New +$15.4K ﹤0.01% 4860

Other funds holding ATNM

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings's ATNM Position: Q2 2026 in Review

Osaic Holdings reduced its Actinium Pharmaceuticals (ATNM) stake by 5% in Q2 2026, selling an estimated $1.16K and leaving 18,865 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6230.

Osaic Holdings first reported a position in ATNM in Q1 2020 and has held it in 26 quarters since. The position peaked at $80.9K in Q1 2024. 47 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

  • Osaic Holdings held 18,865 shares of Actinium Pharmaceuticals worth $18.5K as of Q2 2026.
  • Osaic Holdings sold 1,000 Actinium Pharmaceuticals shares in Q2 2026, an estimated $1.16K.
  • Actinium Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6230 holding.
  • Osaic Holdings first reported a position in Actinium Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Actinium Pharmaceuticals position peaked at $80.9K in Q1 2024.
  • 47 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.